GSK appoints InChord for global cancer drug drive
PHILADELPHIA, US: GlaxoSmithKline has installed global agency backing for its stable of cancer treatments as it seeks to gain a foothold in a market dominated by firms such as Roche, Sanofi-Aventis and Pfizer.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>